[Ways of improving long-term results of treatment in resectable pancreatic cancer].
Patiutko
Iu I
IuI
Kotel'nikov
A G
AG
Badalian
Kh V
KhV
Sagaĭdak
I V
IV
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D007430:Intraoperative Care; D008207:Lymphatic Metastasis; D016685:Mitomycin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D011169:Portal Vein; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D016685:Mitomycin; D005472:Fluorouracil